CICC(03908): China International Capital Corporation Limited will issue corporate bonds (fifth series) to professional investors in 2026. The face interest rate for variety one is 1.67%, and for variety two is 1.80%.
. GF Securities Co., Ltd. (03908) announced that China International Financial Co., Ltd. has been approved by the China Securities Regulatory Commission to publicly issue corporate bonds to professional investors, with a total amount not exceeding 35 billion yuan (including 35 billion yuan), as stated in the approval document (CSRC License [2026] No.154).
CICC (03908) announced that China International Financial Co., Ltd. has received approval from the China Securities Regulatory Commission for the public issuance of corporate bonds to professional investors, with a total amount not exceeding 35 billion yuan (including 35 billion yuan). The bonds are underwritten by China Securities Co., Ltd., Huatai United Securities Co., Ltd., and Shenwan Hongyuan Group Securities Co., Ltd. The issuance includes two categories: category one with a total issuance of up to 40 billion yuan, and category two with a total issuance of up to 40 billion yuan. The total issuance for both categories is not to exceed 40 billion yuan.
The indicative range for the coupon rate for category one is 1.20%-2.20%, and for category two is 1.30%-2.30%. The final coupon rate for the bonds will be determined within the indicated range based on the results of the bookbuilding process conducted by the lead underwriter in accordance with relevant regulations.
On June 16, 2026, the lead underwriter conducted the coupon rate inquiry process with investors. Based on the results of the investor inquiries, the final coupon rate for category one was determined as 1.67%, and for category two was determined as 1.80%.
The issuer will conduct the private placement to institutional investors at the above-mentioned coupon rates from June 17, 2026 to June 18, 2026.
Related Articles

REMEGEN (09995) appointed Liang Wei as the securities affairs representative.

CN HEALTH TECH (01069): The rights issue has been effectively accepted by approximately 28.62%.

US Stock Market Move | The stock of Intel Corporation (INTC.US) fell more than 4% as technology stocks declined across the board.
REMEGEN (09995) appointed Liang Wei as the securities affairs representative.

CN HEALTH TECH (01069): The rights issue has been effectively accepted by approximately 28.62%.

US Stock Market Move | The stock of Intel Corporation (INTC.US) fell more than 4% as technology stocks declined across the board.

RECOMMEND





